Deborah Cromer
Deborah Cromer
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
DS Khoury, D Cromer, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ...
Nature medicine 27 (7), 1205-1211, 2021
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ...
Nature, 1-5, 2021
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
D Cromer, M Steain, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ...
The Lancet Microbe, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ...
Nature communications 12 (1), 1-11, 2021
The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy
D Cromer, AJ van Hoek, M Jit, WJ Edmunds, D Fleming, E Miller
Journal of Infection 68 (4), 363-371, 2014
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
D Cromer, JA Juno, D Khoury, A Reynaldi, AK Wheatley, SJ Kent, ...
Nature Reviews Immunology 21 (6), 395-404, 2021
HIV reactivation from latency after treatment interruption occurs on average every 5-8 days—implications for HIV remission
M Pinkevych, D Cromer, M Tolstrup, AJ Grimm, DA Cooper, SR Lewin, ...
PLoS pathogens 11 (7), e1005000, 2015
Functional cure of HIV: the scale of the challenge
MP Davenport, DS Khoury, D Cromer, SR Lewin, AD Kelleher, SJ Kent
Nature Reviews Immunology 19 (1), 45-54, 2019
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
P Pymm, A Adair, LJ Chan, JP Cooney, FL Mordant, CC Allison, E Lopez, ...
Proceedings of the National Academy of Sciences 118 (19), 2021
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
DS Khoury, AK Wheatley, MD Ramuta, A Reynaldi, D Cromer, ...
Nature Reviews Immunology 20 (12), 727-738, 2020
Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo
AI Adekunle, M Pinkevych, R McGready, C Luxemburger, LJ White, ...
PLoS neglected tropical diseases 9 (3), e0003595, 2015
Preferential invasion of reticulocytes during late-stage Plasmodium berghei infection accounts for reduced circulating reticulocyte levels
D Cromer, KJ Evans, L Schofield, MP Davenport
International journal for parasitology 36 (13), 1389-1397, 2006
Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England
D Cromer, AJ van Hoek, AT Newall, AJ Pollard, M Jit
The Lancet Public Health 2 (8), e367-e374, 2017
Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with …
SK Tey, GA Kennedy, D Cromer, MP Davenport, S Walker, LI Jones, ...
PLOS ONE 8 (10), e74744, 2013
Early analysis of the Australian COVID-19 epidemic
DJ Price, FM Shearer, MT Meehan, E McBryde, R Moss, N Golding, ...
Elife 9, e58785, 2020
The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales
M Jit, D Cromer, M Baguelin, J Stowe, N Andrews, E Miller
Vaccine 29 (1), 115-122, 2010
Mice deficient in the putative phospholipid flippase ATP11C exhibit altered erythrocyte shape, anemia, and reduced erythrocyte life span
M Yabas, LA Coupland, D Cromer, M Winterberg, NC Teoh, J D'Rozario, ...
Journal of Biological Chemistry 289 (28), 19531-19537, 2014
SARS-CoV-2 Omicron: reduction of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
A Aggarwal, AO Stella, G Walker, A Akerman, V Milogiannakis, AC Hoppe, ...
medRxiv, 2021
Identifying recombination hot spots in the HIV-1 genome
RP Smyth, TE Schlub, AJ Grimm, C Waugh, P Ellenberg, A Chopra, ...
Journal of virology 88 (5), 2891-2902, 2014
Safety and reproducibility of a clinical trial system using induced blood stage Plasmodium vivax infection and its potential as a model to evaluate malaria transmission
P Griffin, C Pasay, S Elliott, S Sekuloski, M Sikulu, L Hugo, D Khoury, ...
PLOS Neglected Tropical Diseases 10 (12), e0005139, 2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20